140 related articles for article (PubMed ID: 38246527)
21. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study.
Vuong HG; Nguyen DD; El-Rassi E; Ngo TNM; Dunn IF
World Neurosurg; 2022 Jan; 157():e245-e253. PubMed ID: 34628034
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
[TBL] [Abstract][Full Text] [Related]
23. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic refractory hypercalcemia due to advanced metastatic esthesioneuroblastoma.
Sharma S; Lasheen W; Walsh D
Rhinology; 2008 Jun; 46(2):153-5. PubMed ID: 18575019
[TBL] [Abstract][Full Text] [Related]
25. Metastatic esthesioneuroblastoma recurrence after 19 years of remission: A systematic review with case illustration.
Mozaffari K; Pradhan A; Yang I; Patel K; Vivas AC
J Neurol Sci; 2022 Nov; 442():120406. PubMed ID: 36081302
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma.
Wu L; Liu H; Liu H
Clin Neuropathol; 2023; 42(2):47-53. PubMed ID: 36708210
[TBL] [Abstract][Full Text] [Related]
27. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.
Joshi RR; Husain Q; Roman BR; Cracchiolo J; Yu Y; Tsai J; Kang J; McBride S; Lee NY; Morris L; Ganly I; Tabar V; Cohen MA
J Surg Oncol; 2019 Jan; 119(1):130-142. PubMed ID: 30466166
[TBL] [Abstract][Full Text] [Related]
28. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
29. Esthesioneuroblastoma with widespread distant metastasis: Case report and literature review.
Khosla M; Pecci C; Do A; McGhan L; Seetharam M; Sue R
Ear Nose Throat J; 2018; 97(4-5):E18-E21. PubMed ID: 29940688
[TBL] [Abstract][Full Text] [Related]
30. Esthesioneuroblastoma metastatic to the thoracic intradural and extradural space.
Arnold PM; Habib A; Newell K; Anderson KK
Spine J; 2009 May; 9(5):e1-5. PubMed ID: 18805062
[TBL] [Abstract][Full Text] [Related]
31. Pattern of loco-regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution.
Dumont B; Fresneau B; Claude L; Defachelles AS; Couloigner V; Puget S; Brisse HJ; Fréneaux P; Lacour B; Orbach D
Pediatr Blood Cancer; 2020 Apr; 67(4):e28154. PubMed ID: 31930719
[TBL] [Abstract][Full Text] [Related]
32. Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications.
Zollinger LV; Wiggins RH; Cornelius RS; Phillips CD
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1561-3. PubMed ID: 18499797
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma.
Barinsky GL; Azmy MC; Kilic S; Grube JG; Baredes S; Hsueh WD; Eloy JA
Ann Otol Rhinol Laryngol; 2021 Feb; 130(2):136-141. PubMed ID: 32627574
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetic aberrations of esthesioneuroblastoma studied by comparative genomic hybridization].
You XJ; Petersen I; Arps H; Draf W; Bockmühl U
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):16-21. PubMed ID: 15771791
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
[TBL] [Abstract][Full Text] [Related]
36. [Pediatric esthesioneuroblastoma: an exceptional malignant lesion (a case study and literature review)].
Borni M; Kammoun B; Kolsi F; Boudawara MZ
Pan Afr Med J; 2018; 31():144. PubMed ID: 31037204
[TBL] [Abstract][Full Text] [Related]
37. Esthesioneuroblastoma in children, adolescents and young adults.
Dumont B; Lemelle L; Cordero C; Couloigner V; Bernard S; Cardoen L; Brisse HJ; Jehanno N; Fréneaux P; Helfre S; Rouffiange L; Réguerre Y; Orbach D
Bull Cancer; 2020 Sep; 107(9):934-945. PubMed ID: 32896369
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
Wu L; An J; Liu H
World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
[TBL] [Abstract][Full Text] [Related]
39. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Head Neck; 2021 Apr; 43(4):1097-1104. PubMed ID: 33301222
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and overall survival in pediatric versus adult esthesioneuroblastoma: A population-based study.
Berger MH; Lehrich BM; Yasaka TM; Fong BM; Hsu FPK; Kuan EC
Int J Pediatr Otorhinolaryngol; 2021 May; 144():110696. PubMed ID: 33812144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
